In particular, SSTR2 is highly expressed by neuroendocrine tumors such as gastroenteropancreatic neuroendocrine tumors, pheochromocytoma/paragangliomas [76], and most neuroblastomas (60–90%) [37,82,83,84]. This evidence concerns the gene SSTR2 and neuroendocrine neoplasm.